EGFR and neoplasm: In this study, 52 patients (51.5%) had different EGFR mutation statuses (16 patients had different mutations, and 36 patients had at least one EGFR-wildtype tumor), 20 patients had the same EGFR mutations (19.8%), and 29 patients (28.7%) had only EGFR-wildtype tumors.